In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alcresta Inc.

www.alcresta.com

Latest From Alcresta Inc.

Venture Funding Deals, August 2016

Derived from Strategic Transactions, Informa's premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced June through July 2016.

Commercial Business Strategies

Start-Up Previews, January 2016

In this month's issue of Start-Up, we profile Alcresta Pharmaceuticals, Gordian Surgical, International Biomedical Devices, NaviGate Cardiac Structures, ObsEva and SweetBio.

BioPharmaceutical Medical Device

Alcresta Pharmaceuticals Inc.

Alcresta Pharmaceuticals Inc. aims to combat malabsorption, with an initial focus on enzyme deficiencies, for people with gastrointestinal disorders and rare diseases. It is developing a pipeline of point-of-care nutritional products tailored to maximize the absorption of calories or specific nutrients, based on cartridges enclosing enzymes immobilized onto polymer beads.

BioPharmaceutical Consumer

Alcresta Pharmaceuticals Inc.

Alcresta Pharmaceuticals Inc. aims to combat malabsorption, with an initial focus on enzyme deficiencies, for people with gastrointestinal disorders and rare diseases. It is developing a pipeline of point-of-care nutritional products tailored to maximize the absorption of calories or specific nutrients, based on cartridges enclosing enzymes immobilized onto polymer beads.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Cancer
  • Gastrointestinal
  • Respiratory, Pulmonary
  • Alias(es)
  • Alcresta Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Alcresta Inc.
  • Senior Management
  • Daniel Orlando, CEO
    Tasos Konidaris, CFO
    Eric R First, MD, CSO
  • Contact Info
  • Alcresta Inc.
    Phone: (617) 916-1207
    1 Newton Exec. Park, Ste. 202
    Newton, MA 02462
    USA
UsernamePublicRestriction

Register